Abate As Indust

When is the next results date for Abate As Indust?

No Upcoming Board Meetings

What is the technical trend for Abate As Indust?

As of May 19, 2025, Abate As Indust shows a mildly bearish trend due to daily moving averages and weekly RSI indicating bearish momentum, despite mixed signals from other indicators.

As of 19 May 2025, the technical trend for Abate As Indust has changed from does not qualify to mildly bearish. The current stance is mildly bearish, driven primarily by the daily moving averages indicating a bearish trend and the weekly RSI showing bearish momentum. While the weekly MACD and Bollinger Bands are mildly bullish, the monthly indicators remain bearish, suggesting a lack of strong upward momentum. The Dow Theory indicates no trend on the weekly timeframe, but mildly bullish on the monthly, adding to the mixed signals. Overall, the strength of the bearish stance is supported by the daily moving averages and the weekly RSI.

Who are the peers of the Abate As Indust?

Abate As Indust's peers include Shalby, Dr Agarwal's Eye, GPT Healthcare, and others, with varying management and growth risks. In terms of returns, Abate As Indust has a 1-year return of 46.07%, higher than Shalby's -33.71% but lower than Asarfi Hospital's 92.36%.

Peers: The peers of Abate As Indust are Shalby, Dr Agarwal's Eye, GPT Healthcare, KMC Speciality, Asarfi Hospital, Aashka Hospitals, Chandan Healthca, Aprameya Enginee, and Unihealth Hosp.<BR><BR>Quality Snapshot: Excellent management risk is observed at GPT Healthcare and Chandan Healthca, while Good management risk is found at Shalby, Asarfi Hospital, Aprameya Enginee, and Unihealth Hosp. Average management risk is present at Dr Agarwal's Eye, KMC Speciality, and Aashka Hospitals, while Below Average management risk is noted at Aashka Hospitals. Abate As Indust does not qualify for management risk assessment. In terms of growth, Excellent growth is seen at Chandan Healthca and Aprameya Enginee, while Average growth is found at Dr Agarwal's Eye and Unihealth Hosp. Below Average growth is noted at Shalby, GPT Healthcare, KMC Speciality, Asarfi Hospital, and Aashka Hospitals. Abate As Indust does not qualify for growth assessment. For capital structure, Excellent capital structure is observed at GPT Healthcare and KMC Speciality, while Good capital structure is found at Shalby and Asarfi Hospital. Average capital structure is noted at Dr Agarwal's Eye and Unihealth Hosp, while Below Average capital structure is seen at Aashka Hospitals and Abate As Indust does not qualify for capital structure assessment.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Asarfi Hospital at 92.36%, while the lowest is Shalby at -33.71%. Abate As Indust has a 1-year return of 46.07%, which is significantly higher than Shalby but lower than Asarfi Hospital. Additionally, KMC Speciality, Aashka Hospitals, and Shalby have negative six-month returns.

Who are in the management team of Abate As Indust?

As of March 2018, the management team of Abate As Indust includes Kamlesh B Mehta (Executive Director), Visswas B Panse (Independent Non-Executive Director), and Ashok Bhanushali (Non-Executive Director).

As of March 2018, the management team of Abate As Indust includes the following members:<BR><BR>1. Kamlesh B Mehta - Executive Director<BR>2. Visswas B Panse - Independent Non-Executive Director<BR>3. Ashok Bhanushali - Non Executive Director<BR><BR>These individuals are part of the company's Board of Directors.

What does Abate As Indust do?

Abate As Industries Ltd specializes in accounting and finance software for the hospital industry, with a market cap of INR 340 Cr and a recent quarterly profit of 6 Cr as of March 2025. The company has a high P/E ratio of 315.00 and a low return on equity of -0.18%.

Overview:<BR>Abate As Industries Ltd is a specialist in accounting software packages and finance software packages, operating within the hospital industry and categorized as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in an unspecified year, with no status changes reported. The latest quarter for which sales and profit are reported is March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: 6 Cr (Quarterly Results - Mar 2025)<BR>Market-cap value: INR 340 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 315.00<BR>Industry P/E: 35<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.01<BR>Return on Equity: -0.18%<BR>Price to Book: 2.07<BR><BR>Contact Details:<BR>Address: Siddhart Nagar No 5 S V Road, Chawl 19/168 Goregaon West Mumbai Maharashtra : 400062<BR>Email: k4kamleshm@yahoo.com<BR>Website: http://www.abateas.com

Who are the top shareholders of the Abate As Indust?

The top shareholders of Abate As Indust are the Al Salama Eye Research Foundation with 12.75%, followed by Kanta Devi Samdaria at 2.39%, while individual investors hold a combined 58.46%. There are no institutional holdings from mutual funds or foreign investors.

The top shareholders of Abate As Indust include the Al Salama Eye Research Foundation, which holds the largest stake at 12.75%. The highest public shareholder is Kanta Devi Samdaria, with a holding of 2.39%. Additionally, individual investors collectively hold a significant portion of 58.46%. There are no institutional holdings from mutual funds or foreign institutional investors.

Is Abate As Indust overvalued or undervalued?

As of July 17, 2025, Abate As Indust is considered very expensive and overvalued, with a PE ratio of 321.59, significantly higher than its peers, and a recent stock performance of 111.65% compared to the Sensex's 0.83%.

As of 17 July 2025, the valuation grade for Abate As Indust has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 321.59, an EV to EBIT of 362.63, and an ROE of 0.67%. <BR><BR>In comparison to its peers, Abate As Indust's valuation metrics are starkly high; for instance, Elitecon International has a PE ratio of 273.4, while Lloyds Enterprises stands at 178.83. This suggests that Abate As Indust is priced at a premium compared to its competitors. Additionally, the company's recent stock performance has outpaced the Sensex, with a 1-month return of 111.65% compared to the Sensex's 0.83%, reinforcing the notion of an inflated valuation.

How big is Abate As Indust?

As of 24th July, Abate As Industries Ltd has a market capitalization of 383.00 Cr, with reported Net Sales of 0.00 Cr and a Net Profit loss of 1.86 Cr in the latest four quarters. Shareholder's Funds are valued at 163.79 Cr, and Total Assets amount to 205.47 Cr.

As of 24th July, Abate As Industries Ltd has a market capitalization of 383.00 Cr, categorized as a Micro Cap.<BR><BR>In the latest four quarters, the company reported Net Sales of 0.00 Cr and a Net Profit loss of 1.86 Cr.<BR><BR>For the latest annual period, the Shareholder's Funds were valued at 163.79 Cr, while the Total Assets amounted to 205.47 Cr.

How has been the historical performance of Abate As Indust?

Abate As Indust reported an operating income of 14.09 Cr and a profit after tax of 1.11 Cr for the year ending March 2025, with an EPS of 0.07 and strong profit margins of 5.25% and 7.81%. The company has total liabilities of 205.47 Cr and shareholder's funds of 163.79 Cr, indicating a solid financial position.

Answer:<BR>The historical performance of Abate As Indust shows a total operating income of 14.09 Cr for the year ending March 2025, with a total expenditure of 13.35 Cr, resulting in an operating profit (PBDIT) of 1.71 Cr. After accounting for interest and depreciation, the profit before tax stands at 1.10 Cr, leading to a profit after tax of 1.11 Cr. The earnings per share (EPS) for the same period is reported at 0.07. The company maintains a strong operating profit margin of 5.25% and a profit after tax margin of 7.81%. <BR><BR>Breakdown:<BR>Abate As Indust reported a total operating income of 14.09 Cr, with raw material costs and other operating expenses contributing to a total expenditure of 13.35 Cr. This resulted in an operating profit of 1.71 Cr, which, after deducting interest and depreciation, led to a profit before tax of 1.10 Cr and a profit after tax of 1.11 Cr. The company’s earnings per share is 0.07, reflecting its profitability. The operating profit margin is 5.25%, while the profit after tax margin is notably higher at 7.81%. On the balance sheet, total liabilities amount to 205.47 Cr, with shareholder's funds at 163.79 Cr, indicating a solid financial foundation. The cash flow from financing activities shows a net inflow of 164.00 Cr, contributing to a closing cash equivalent of 1.00 Cr.

Are Abate As Industries Ltd latest results good or bad?

Abate As Industries Ltd's latest results are concerning, with a 24.82% decline in net profit to ₹3.06 crore despite a slight revenue increase of 1.33% to ₹42.69 crore. While operational efficiency improved, the significant drop in other income and overall profitability raises red flags about the company's financial health.

Abate As Industries Ltd's latest results present a mixed picture. In Q3 FY26, the company reported a net profit of ₹3.06 crore, which is a significant decline of 24.82% compared to the previous quarter's profit of ₹4.07 crore. This drop in net profit raises concerns about the sustainability of its profitability, especially following the extraordinary growth of 80.89% in the prior quarter.<BR><BR>On the positive side, the company's revenue for the quarter was ₹42.69 crore, reflecting a modest growth of 1.33% from ₹42.13 crore in Q2 FY26. This indicates that while the company is maintaining a solid revenue run rate, the growth momentum has slowed considerably compared to previous quarters.<BR><BR>Additionally, the operating margin improved to 9.23%, the highest in four quarters, which suggests some operational efficiency gains. However, the net profit margin contracted to 7.17%, primarily due to a sharp decline in other income, which fell by nearly 95% from the previous quarter.<BR><BR>Overall, while Abate As Industries has shown some operational improvements, the decline in net profit and the volatility in other income raise red flags about its financial health. The stock has also experienced significant volatility, trading 47% below its 52-week high, which reflects investor uncertainty. Therefore, the results can be viewed as concerning, particularly regarding profitability and valuation sustainability.

Should I buy, sell or hold Abate As Industries Ltd?

Why is Abate As Industries Ltd falling/rising?

As of 05-May, Abate As Industries Ltd's stock price is at Rs 10.37, down 3.08%, and has significantly underperformed the Sensex, with a year-to-date decline of 40.74%. The stock is trading below all moving averages and is nearing its 52-week low, indicating a bearish trend and reduced investor participation.

As of 05-May, Abate As Industries Ltd's stock price is falling, currently at Rs 10.37, which reflects a decrease of Rs 0.33 or 3.08%. This decline is evident in the stock's performance over various periods; it has dropped by 3.45% over the past week and 8.07% over the past month, significantly underperforming the Sensex, which has increased by 0.17% and 5.04% respectively during the same time frames. Year-to-date, the stock has plummeted by 40.74%, while the Sensex has only decreased by 9.63%.<BR><BR>Additionally, the stock is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. The stock is also close to its 52-week low, being only 3.29% away from it. Furthermore, there has been a notable decline in investor participation, with delivery volume dropping by 54.74% compared to the 5-day average. These factors collectively contribute to the downward pressure on Abate As Industries Ltd's stock price.

Which are the latest news on Abate As Indust?